Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 14, 2025 • 5:30 AM ET

Date/Time Source News Release
08/12/2025 04:05 PM EDT GlobeNewswire Fractyl Health Announces Second Quarter 2025 Financial Results and Business Updates
08/07/2025 04:05 PM EDT GlobeNewswire Fractyl Health Announces Closing of $23 Million Underwritten Public Offering Including Full Exercise of Underwriter's Option to Purchase Additional Shares
08/06/2025 04:05 PM EDT GlobeNewswire Fractyl Health to Report Second Quarter 2025 Financial Results and Provide Business Updates on August 12, 2025, and Will Participate in an Upcoming Investor Conference
08/06/2025 08:30 AM EDT GlobeNewswire Fractyl Health Announces Pricing of $20 Million Underwritten Public Offering
08/05/2025 04:02 PM EDT GlobeNewswire Fractyl Health Reports Potent and Durable Two-Year Real-World Outcomes with Revita® Showing Sustained Weight Loss and Improved Glucose Control After a Single Procedure
06/23/2025 07:40 AM EDT GlobeNewswire Fractyl Health Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita® Sustained Weight Loss After GLP-1 Discontinuation, Supporting its Potential as a First-in-Class Weight Maintenance Therapy
06/23/2025 07:30 AM EDT GlobeNewswire Fractyl Health Presents New Data at the American Diabetes Association's 85th Scientific Sessions Demonstrating its Rejuva® Smart GLP-1(TM) Pancreatic Gene Therapy Platform Prevents Obesity and Type 2 Diabetes in Preclinical Models
06/18/2025 07:00 AM EDT GlobeNewswire Fractyl Health Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing
06/13/2025 07:00 AM EDT GlobeNewswire Fractyl Health to Present New Preclinical Data from its Rejuva® Smart GLP-1(TM) Pancreatic Gene Therapy Platform at the American Diabetes Association's 85th Scientific Sessions
06/04/2025 07:00 AM EDT GlobeNewswire Fractyl Health and Bariendo Sign Letter of Intent to Prepare for Potential Offering of Revita® Across its Bariatric and Metabolic Endoscopy Centers Nationwide
Page

Additional News

As of August 14, 2025 • 5:30 AM ET

Date/Time Source News Release
08/12/2025 08:01 PM EDT SeekingAlpha Fractyl Health outlines upcoming REMAIN-1 and Rejuva milestones while strengthening cash position
08/12/2025 08:00 PM EDT SeekingAlpha Fractyl Health, Inc. (GUTS) Q2 2025 Earnings Call Transcript
08/12/2025 04:23 PM EDT SeekingAlpha Fractyl Health reports Q2 results
08/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Tuesday, August 12th, 2025
08/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Fractyl Health, Inc.
08/11/2025 06:45 PM EDT KlickAnalytics GUTS - Historical Price Movements Surrounding Earnings
08/11/2025 06:40 PM EDT KlickAnalytics GUTS - Historical Earnings Price Analysis
08/06/2025 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Wed, Aug 06, 2025 as of 4:00 pm ET
08/06/2025 02:00 PM EDT PRISM News PRISM Mid-Day Movers: Telehealth Turbulence and Global Health Dilution
08/06/2025 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Wed, Aug 06, 2025 as of 10.00 am ET
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.